Thermo Fisher Scientific Inc. (TMO) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Waltham, MA, United States. Der aktuelle CEO ist Marc N. Casper.
TMO hat IPO-Datum 1980-03-17, 125,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $195.85B.
Thermo Fisher Scientific Inc. is a global life sciences company headquartered in Waltham, Massachusetts, providing comprehensive solutions across analytical instruments, specialty diagnostics, and laboratory products for pharmaceutical, biotechnology, academic, and clinical markets worldwide. The company operates through four main segments: Life Sciences Solutions, which offers reagents and instruments for drug discovery and vaccine production; Analytical Instruments, providing testing equipment for research and industrial applications; Specialty Diagnostics, delivering immunodiagnostic systems and clinical testing solutions; and Laboratory Products and Biopharma Services, supporting pharmaceutical development and clinical research. Thermo Fisher serves customers across North America, Europe, Asia-Pacific, and internationally through its portfolio of leading brands including Thermo Scientific, Applied Biosystems, Invitrogen, and Fisher Scientific, distributing products via direct sales, e-commerce, and third-party partners. Founded in 1956, the company has established itself as a critical infrastructure provider enabling scientific advancement and healthcare innovation globally.
